The VAD Journal: The journal of mechanical assisted circulation and heart failure

Peer-Reviewed Case Report

Paranormal activity: Para-Esophageal/Gastric
Hemorrhage in a Patient with a HeartMate II LVAD
Anna Stone* and Ashwin Ravichandran
St Vincent's Indianapolis/Heart Center of Indiana, Indianapolis, IN
Corresponding author: annasleder@gmail.com
Citation: Stone A.et al. (2017)
“Paranormal activity: ParaEsophageal/Gastric Hemorrhage in
a Patient with a HeartMate II
LVAD”.
The VAD Journal, 3. doi:
https://doi.org/10.13023/VAD.2017.
07
Editor-in-Chief: Maya Guglin,
University of Kentucky
Received: Aril 14, 2017
Accepted May 24, 2017

Abstract
In this report we present an unusual case of non-traumatic, spontaneous paraesophageal/para-gastric hemorrhage requiring multiple units of red blood cells in a
female patient with a continuous flow left ventricular assist device. She presented
with dysphagia and atypical chest pain 18 months post implantation, on the
recommended anticoagulation regimen for HeartMate II support of ASA 81mg and
international normalized ratio goal (INR) of 2-3 and was successfully managed
with conservation support, volume resuscitation and multiple transfusions. Nontraumatic causes of acute bleeding, including acquired platelet dysfunction are
considered.
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Introduction
Mechanical circulatory support in the form of left ventricular assist devices
(LVADs) have become the standard-of-care for selected patients with end-stage
heart failure refractory to medical therapy. Despite the improved survival in
patients with the evolution in design from pulsatile flow to continuous flow (CF)
devices, bleeding complications remain a significant problem, not the least of
which is gastrointestinal (GI) bleeding. 1 In addition to the risks of bleeding related
to anticoagulation, GI bleeding in CF LVADs has been attributed to the
development of acquired von Willebrand disease (aVWD), diminished pulse
pressure and pulsatility, advanced age, history of peptic ulcer disease, and
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increased pump speed. 2- 4 Evidence of spontaneous bleeding from other anatomic
sites are less well-described. We present a case of a spontaneous paraesophageal/gastric hemorrhage in a patient with a CF LVAD who was greater than
one year post device implantation.

Case report
The patient was a 38 year old African American female with a history of nonischemic cardiomyopathy status post HeartMate II in February of 2015, obesity
(BMI of 48), and dysfunctional uterine bleeding after LVAD controlled with an
intrauterine device. The patient reported her usual state of health and had no
significant prior LVAD complications until the day of presentation when she awoke
with sudden onset, sharp, severe chest and back pain, dysphagia, nausea, and
vomiting with clear emesis. Computed tomography with angiogram (CTA) of the
chest revealed no signs of dissection, but did reveal a 7.5 x5.9 cm hypodense
lesion posterior to the left lobe of the liver and anterior to the stomach, with mild
dilation of the distal esophagus and air/fluid levels seen in the proximal
esophagus. Initial labs were notable for an INR of 2.86 and hemoglobin of 8.4g/dl
(baseline ~9.5g/dl), which rapidly decreased to 6.7g/dl over the next few hours.
The severe chest pain and vomiting continued, and with the assistance of the
gastrointestinal (GI) team, a nasogastric tube was endoscopically placed, and
visual examination revealed severe, diffuse mucosal changes concerning for
ischemia from external compression. A subsequent barium swallow revealed a
large mass concerning for hematoma, likely external to the esophagus, causing
severe luminal narrowing and a high degree of obstruction (Figure 1). Repeat
CTA revealed a much larger (9.1x 4.5x 10cm), evolving hematoma (Figure 2)
which also resulted in gastric compression (Figure 3).

Figure 1. Esophagram revealing paraesophageal hematoma with
esophageal obstruction
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Figure 2. Cross and coronal sections of CTA of chest revealing paraesophageal and para-gastric hematoma with LVAD.

Figure 3. Sagittal section of CT with oral contrast revealing
paraesophageal/paragastric hematoma causing gastric compression.
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After volume and transfusion resuscitation, reversal of anticoagulation with fresh
frozen plasma, and surgical evaluation, conservative management was
undertaken given her clinical stability with no other source of bleeding despite
interventional angiographic evaluation. She then tolerated increasing doses of
intravenous heparin, was bridged to warfarin and kept nothing per os (NPO) other
than medications for several days due to concerns over ischemic esophagitis. She
slowly progressed to mechanical soft diet at time of discharge with mild residual
dysphagia, 16 days after presentation.

Discussion
The association between CF LVADs and bleeding diatheses are well-known, in
part due to the aforementioned phenomenon of aVWD, resulting from the sheer
stress on the von Willebrand factor from the CF-LVAD leading to platelet
dysfunction.5 Another mechanism independent and specifically related to the
increased risk of GI bleeding in CF LVADs is similar to that of Heyde’s syndrome
seen in aortic stenosis. Heyde’s syndrome is the theory of an abnormal pulse
wave resulting in the distention of sub-mucosal venous plexuses of the GI tract,
subsequent angiodysplasia and arteriovenous malformations (AVMs)with poorly
perfused, and friable gastrointestinal mucosa.6 To our knowledge, this is the first
report of a spontaneous paraesophageal/mucosal bleed that is not related to the
common GI or perioperative bleeding reported in this population. Understanding
the other potential mechanisms and risk factors for increased bleeding in LVAD
patients is crucial to the prevention and treatment of morbidity and mortality in this
already high risk population.
How sex or BMI influences the risks of these types of bleeds have yet to be
elucidated. Recently, an increased incidence of thrombotic and hemorrhagic
events have been identified in the female HeartMate II population as compared to
males,7 with a more recent single center report identifying an increase in bleeding
complications in females regardless of CF-LVAD type.8 Additionally, there is a
higher risk of bleeding in patients with lower body mass index (BMI), which is
clearly not the case for this patient with a BMI of 48.9 Taking all of this into
consideration along with an INR within therapeutic range, determining the etiology
of our patient’s spontaneous paraesophageal/mucosal bleed remains a challenge.
Currently the mainstay of prevention for bleeding in LVAD patients is mechanical
and pharmacologic intervention including monitoring INRs closely and reducing
pump speed, which may be associated with decreased bleeding.4 Blood pressure
control is important in reducing risk of intracerebral bleeding. Determining the
risks, prevention and treatment of bleeding not only impacts short-term morbidity,
but also has several long-term implications. For example, patients with LVADs
who have experienced GI bleeding have a decrease in future heart transplant
probability. While the mechanism of this relationship is unclear, speculation
regarding allosensitization from receiving blood products prior to heart transplant is
purported. 10 Further research and reports on bleeding in this patient population is
crucial to discovering targeted methods for the prevention and treatment of
bleeding and its associated implications on morbidity and mortality in the LVAD
population.
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